Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00064870 · ClinicalTrials.gov registry record
Alzheimer's Disease Genetics Study
A clinical trial of Alzheimer Disease and Dementia, sponsored by Indiana University.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT00064870: Recruiting study of Alzheimer Disease and Dementia, sponsored by Indiana University.
NCT00064870 is a study of Alzheimer Disease and Dementia that is actively recruiting participants, run by Indiana University. The registered enrollment target is 10,000 participants, above the 2,718-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (268% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00064870, a study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.
Primary Outcome
Investigators will analyze the samples and publish de-identified results. These publications will help to further the knowledge in the field of dementia and potentially lead to new therapies and targets for therapies.
Conditions Studied
Study Locations (1)
Indiana
- Participants are being recruited from all over the United States - Nationwide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2002-06 |
| Est. Completion | 2026-07 |
What NCT00064870 shows while recruiting
NCT00064870 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,718-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (268% higher).
The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00064870 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT00064870 about?
NCT00064870 is a clinical study titled "Alzheimer's Disease Genetics Study". The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple...
What is the current status of trial NCT00064870?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2002-06. Estimated completion is 2026-07.
What conditions does trial NCT00064870 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Late Onset Alzheimer Disease.
Who is sponsoring clinical trial NCT00064870?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00064870 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00064870's enrollment target sits among peer trials
10,000 10th of 306 higher than 294 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
RECRUITING · Phase 3
-
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
RECRUITING · Phase 4
-
Systemic and Central Inflammation in AD
RECRUITING · Phase 2
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
RECRUITING · Phase 1
-
Cognitive Neurology Unit Clinical Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia